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Interneuronal DISC1 regulates NRG1-ErbB4
signalling and excitatory–inhibitory synapse
formation in the mature cortex
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Neuregulin-1 (NRG1) and its receptor ErbB4 influence several processes of neurodevelop-
ment, but the mechanisms regulating this signalling in the mature brain are not well known.
DISC1 is a multifunctional scaffold protein that mediates many cellular processes. Here we
present a functional relationship between DISC1 and NRG1-ErbB4 signalling in mature cortical
interneurons. By cell type-specific gene modulation in vitro and in vivo including in a mutant
DISC1 mouse model, we demonstrate that DISC1 inhibits NRG1-induced ErbB4 activation and
signalling. This effect is likely mediated by competitive inhibition of binding of ErbB4 to
PSD95. Finally, we show that interneuronal DISC1 affects NRG1-ErbB4-mediated phenotypes
in the fast spiking interneuron-pyramidal neuron circuit. Post-mortem brain analyses and
some genetic studies have reported interneuronal deficits and involvement of the DISC1, NRG1
and ErbB4 genes in schizophrenia, respectively. Our results suggest a mechanism by which
cross-talk between DISC1 and NRG1-ErbB4 signalling may contribute to these deficits.
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C
lassic linkage/association and copy number variations
studies have suggested that neuregulin-1 (NRG1) and its
receptor ErbB4 are implicated in psychiatric disorders1–4.
NRG1-ErbB4 signalling was initially studied in the context of
neurodevelopment. This cascade is important in guiding several
aspects of cortical maturation including radial migration of
pyramidal neurons, tangential migration of interneurons and
myelination5.
In the cerebral cortex of the postnatal brain, NRG1-ErbB4
signalling enhances excitatory synapse formation on interneurons
and inhibitory synapse formation on pyramidal neurons6–8. In
the cortex, ErbB4 is primarily expressed in interneurons,
particularly in parvalbumin (PV)-positive interneurons6,9,10. At
the electrophysiological level, NRG1-ErbB4 signalling increases
miniature excitatory postsynaptic current (mEPSC) frequency
and amplitude in interneurons, and increases miniature
inhibitory postsynaptic current frequency in pyramidal
neurons6,11,12. Interneuronal ErbB4 also affects dendritic spine
density and excitatory synapse formation in pyramidal
neurons7,13. These results show that NRG1 signalling, via
ErbB4 in interneurons, plays a critical role in regulating
excitatory–inhibitory (E–I) balance in the cortex. Given that the
E–I imbalance may underlie the pathophysiology of mental
disorders such as schizophrenia14,15, it is crucial to elucidate the
mechanism(s) by which NRG1-ErbB4 signalling is regulated in
interneurons of the adult cortex.
The gene coding for DISC1 was originally identified at the
breakpoint of a balanced translocation co-segregated with mental
illnesses including schizophrenia and major depression in a large
Scottish pedigree16. Biological studies exploring the physiological
roles of DISC1 have demonstrated that it is crucial in
neurodevelopment and neural signalling in the adult brain17–19.
Although most of these studies have focused on pyramidal
neurons in the cortex and newborn neurons in the dentate
gyrus20–23, DISC1 is also expressed in cortical interneurons24,25.
Accordingly, recent studies in mice carrying a point mutation in
the Disc1 gene or knockdown of Disc1 by short hairpin RNA
(shRNA) have shown deficits in interneuronal migration and
positioning during development26,27. However, the function of
DISC1 in interneurons in the mature cortex remains to be
elucidated.
In the present study, we provide evidence that DISC1
modulates NRG1-ErbB4 signalling in interneurons. The protein
interaction of ErbB4 and postsynaptic density protein-95
(PSD95) is critical to NRG1-ErbB4 signalling28,29. In addition,
DISC1 is known to interact with and regulate PSD95-associated
proteins20. Here we suggest that the influence of DISC1 on
NRG1-induced ErbB4 activation is likely mediated by competitive
inhibition of binding of ErbB4 to PSD95. We directly
demonstrate that selective modulation of interneuronal DISC1
affects NRG1-ErbB4-mediated phenotypes at the fast spiking
interneuron-pyramidal neuron circuit level, which in turn
regulates E–I circuitry in the mature cortex.
Results
Interneuronal DISC1 regulates ErbB4 signalling in vitro. Both
DISC1 and ErbB4 interact with PSD95 (refs 20,28). ErbB4 is
expressed in PV-positive interneurons in the cortex6,10. DISC1 is
also reportedly expressed in interneurons24,25, and we confirmed
its expression in PV-positive interneurons in the cortex
(Supplementary Fig. 1a). We therefore hypothesized that DISC1
may influence NRG1-ErbB4 signalling via association with the
PSD95 scaffold in interneurons. To test this, we first examined
whether DISC1 knockdown affects NRG1-induced ErbB4
activation in vitro. As ErbB4 is a receptor tyrosine kinase,
which undergoes phosphorylation upon activation by NRG1,
phospho-ErbB4 (pErbB4) immunoreactivity can be used as an
indicator of NRG1-ErbB4 signalling30. Green fluorescent protein
(GFP) expression was similar across conditions (Supplementary
Fig. 1b). Immunoreactivity to pErbB4 was observed in the cell
body and processes (Supplementary Fig. 1c). The specificity of
ErbB4 and pErbB4 antibodies was confirmed in vitro and in vivo
(Supplementary Fig. 2a–d). Western blots detected by all major
antibodies were quantified within their linear ranges (Supple-
mentary Fig. 3a–c). Full-length versions of all blots are provided
in Supplementary Figs 11 and 12. The epidermal growth factor-
like domain of NRG1 is known to be necessary and sufficient for
binding with ErbB4 and activation of NRG1-ErbB4 signalling31.
Using primary cortical neuron cultures in which B20% cells are
in interneuronal populations32, we confirmed that treatment with
a recombinant protein consisting of the epidermal growth factor-
like domain of NRG1 (hereafter referred to as NRG1) induced
ErbB4 activation, detected by pErbB4 immunoreactivity
(Supplementary Fig. 2d).
To test the role of DISC1 on NRG1-ErbB4 signalling, we then
used lentiviral infection to express control or DISC1 shRNA in
primary neuron cultures, followed by NRG1 treatment. This
approach results in DISC1 knockdown in a majority of cells
(Supplementary Fig. 4a), a necessary proportion for observing
changes at the biochemical level. We found that the level of
pErbB4 was significantly augmented by NRG1 treatment (5 nM,
15 min), whereas total ErbB4 expression was unchanged (Fig. 1a).
This augmentation was significantly greater in cells expressing
DISC1 shRNA compared with those with control shRNA,
suggesting that DISC1 knockdown enhances activation of ErbB4
by NRG1 (Fig. 1a). We confirmed that this effect was reversed by
lentiviral co-expression of shRNA-resistant DISC1 (‘DISC1
rescue’; Supplementary Fig. 4b). This experiment indicated that
the enhancement of ErbB4 activation by DISC1 shRNA is not an
off-target effect but is in fact mediated by knockdown of
endogenous DISC1. These findings are consistent with previous
studies demonstrating that DISC1 shRNA-induced phenotypes
were specifically normalized by co-expression of shRNA-resistant
DISC1 (refs 20,33–35).
ErbB4 is expressed almost exclusively in interneurons6,10 and
our mixed cultures contain a substantial interneuronal
population36. We therefore interpret these biochemical data as
an interneuron-specific enhancement of ErbB4 activation.
To support this interpretation, we first confirmed that
pErbB4 immunoreactivity was only detected in interneurons by
observing co-localization of pErbB4 with glutamic acid decar-
boxylase (GAD67), an interneuronal marker. A majority of
pErbB4-positive cells were GAD67 positive (91±1.8%,
mean±s.e.m.; Fig. 1b). We then quantified the effect of DISC1
knockdown on NRG1-ErbB4 signalling by immunocytochemistry
for pErbB4. We again found that NRG1-induced ErbB4
activation, measured by interneuron-specific pErbB4 immuno-
reactivity, was significantly greater in cells expressing DISC1
shRNA compared with those with control shRNA (Supple-
mentary Fig. 4c). This increase was similar in magnitude to that
observed in Fig. 1a, indicating that our biochemical results
accurately reflect an interneuron-specific effect of DISC1 on
ErbB4 activation.
To determine whether this enhancement of NRG1-ErbB4
signalling was a cell-autonomous effect of interneuronal DISC1,
we expressed control or DISC1 shRNA and GFP in cultured
primary neurons by plasmid transfection, rather than lentiviral
infection as above. By virtue of the very low transfection efficiency
of the reagent used (less than 5–10%), shRNA-expressing neurons
in transfected cultures are surrounded by non-transfected cells
in which DISC1 is unaffected (Supplementary Fig. 5a). Thus,
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functional interactions between cells with DISC1 knockdown are
negligible and changes observed in DISC1 shRNA-expressing
neurons likely reflect cell-autonomous effects of DISC1. Cultures
were treated with NRG1 and co-stained for pErbB4 and GAD67,
in order to restrict analysis to transfected interneurons. In this
experimental condition, ErbB4 activation (indicated by pErbB4
immunoreactivity) following NRG1 treatment was significantly
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Figure 1 | Interneuronal DISC1 knockdown enhances NRG1-induced ErbB4 activation and signalling in interneurons in vitro. (a) Western blot for ErbB4
and pErbB4 in lysates from mature primary cortical neurons infected with shRNA (Control (Cont) or DISC1) and treated with NRG1. Cells with DISC1
shRNA showed a greater NRG1-induced increase in pErbB4 signal. (b) Immunostaining for pErbB4 and GAD67 in mature primary cortical neurons. pErbB4
signal co-localized with GAD67 (arrowhead), confirming interneuron-specific expression of ErbB4. Ninety-one percent of pErbB4-positive (pErbB4þ ) cells
were GAD67-positive (GAD67þ ; N¼ 5 cultures). (c) Immunostaining for pErbB4 and GAD67 in mature primary cortical neurons, mock transfected or
transfected with shRNA (Cont or DISC1, GFP co-expressed) and treated with NRG1. GAD67-positive interneurons with DISC1 knockdown showed greater
NRG1-induced pErbB4 immunoreactivity (arrowheads). (d) Immunostaining for pErk and GAD67 in mature primary cortical neurons transfected with
shRNA (Cont or DISC1, GFP co-expressed) and treated with NRG1. GAD67-positive interneurons with DISC1 shRNA showed a greater NRG1-induced
increase in pErk immunoreactivity. Blue signal in images represents 4,6-diamidino-2-phenylindole stain. N425 cells per condition. Data are represented as
mean±s.e.m. *Po0.05, **Po0.01, ***Po0.001; scale bars, 10 mm.
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shRNA (Fig. 1c). This indicates that increased ErbB4 activation is
a result of reduced interneuronal DISC1. Finally, we used the
same experimental system to assess whether NRG1-induced
phosphorylation of extracellular signal-regulated kinase (Erk), a
downstream effector of ErbB4 (ref. 5), was also enhanced by
DISC1 knockdown. Erk phosphorylation was significantly
increased in GAD67-positive cells expressing DISC1 shRNA
compared with control shRNA (Fig. 1d). Erk phosphorylation
was not significantly changed in GAD67-negative cells, indicating
that this effect on NRG1-ErbB4 downstream signalling is
a cell autonomous and interneuron-specific effect of DISC1
(Supplementary Fig. 5b).
Interneuronal DISC1 regulates ErbB4 signalling in vivo. To
address whether knockdown of DISC1 also enhances ErbB4
activation in vivo, we first used a Disc1 locus impairment (LI)
model, in which the majority of Disc1 isoforms are abolished
(Supplementary Fig. 6)37. A significant increase in activation of
ErbB4 was observed at the biochemical level in cortical extracts
from Disc1-LI mice compared with those from wild-type (WT)
littermates (Fig. 2a). This observation was validated by
immunohistochemistry for pErbB4, an established marker for
ErbB4 activation (Fig. 2b). Disc1-LI mice did not show a
significant difference in total numbers of PV interneurons in
the cortex (Supplementary Fig. 7). Expression of NRG1 was
unchanged in the Disc1-LI model, suggesting that this effect was
more likely attributable to a postsynaptic change in regulation of
existing NRG1-ErbB4 signalling, rather than an overall increase
in NRG1 signalling (Supplementary Fig. 8a). As pErbB4
immunoreactivity is restricted to PV interneurons in vivo
(Supplementary Fig. 8b), this effect is likely attributable to PV
interneurons.
To address whether this effect was cell-autonomous, we
knocked down DISC1 in a PV-positive interneuron-specific
manner. This was accomplished using an adeno-associated virus
(AAV) that expresses control or DISC1 shRNA, together with
GFP, downstream of a floxed stop codon. AAV was stereo-
taxically injected into the cortex of PV-Cre mice, resulting in
selective expression of shRNA and GFP in PV interneurons.
The Cre-dependence and PV interneuron-specificity of GFP
expression were verified in vitro and in vivo, respectively
(Supplementary Fig. 8c–e). We confirmed that knockdown of
DISC1 expression was restricted to GFP- and PV-positive
interneurons in the mice (Fig. 2c). Consistent with in vitro
results, we observed increased ErbB4 activation in interneurons
following DISC1 knockdown (Fig. 2d). Downstream Erk
signalling was also enhanced in these cells (Fig. 2e).
DISC1 interferes with ErbB4–PSD95 interaction. As described
above, both ErbB4 and DISC1 have been reported to interact
with PSD95 (refs 20,28). ErbB4–PSD95 interaction facilitates
NRG1-mediated activation of ErbB4 (ref. 29). We therefore
hypothesized that DISC1 may affect ErbB4 activation by
regulating its interaction with PSD95. To test this idea, we
examined whether ErbB4-PSD95 binding is affected by DISC1
knockdown or genetic deletion of DISC1 isoforms. We found that
ErbB4–PSD95 interaction was increased in primary neuron
cultures infected with DISC1 shRNA virus compared with control
shRNA-infected cells (Fig. 3a). This was shown by an increase of
PSD95 in ErbB4 precipitates in which the immunoreactivity of
p-tyrosine is also increased (indicating an increase of pErbB4, as
described above; Fig. 3a). ErbB4–PSD95 interaction and ErbB4
activation were also augmented in cortical extracts from Disc1-LI
mice compared with those from WT controls (Fig. 3b). These
results suggest that DISC1 inhibits ErbB4-PSD95 binding in vitro
and in vivo.
To assess whether DISC1 knockdown affects expression of
PSD95 or trafficking to excitatory synapses, we measured synaptic
PSD95 in cultured primary neurons transfected with control or
DISC1 shRNA (Supplementary Fig. 9). As no significant changes
in synaptic PSD95 levels were observed, we hypothesized that
DISC1 may interfere with ErbB4 binding to PSD95 by a
competitive mechanism. To address this possibility, we
determined the binding domain of PSD95 for DISC1 using a
series of PSD95 deletion constructs that were generated based on
established domain structures of PSD95 (refs 38,39; see
Supplementary Methods for details). Deletion of the first two
PDZ domains of PSD95, an area crucial for binding with ErbB4
(refs 28,40), also significantly reduced PSD95 interaction with
DISC1 (Fig. 3c). Thus, ErbB4 and DISC1 may compete with each
other for PSD95 binding by the same domains.
To test the importance of DISC1–PSD95 interaction in the
regulation of ErbB4–PSD95 interaction, we first determined the
binding domain of DISC1 for PSD95 using a series of DISC1
deletion constructs. Protein product from a construct containing
the first 697 amino acids from the N-terminus of DISC1
(DISC1-N-697) was able to bind to PSD95, whereas protein
product from a construct containing the first 671 amino acids
(DISC1-N-671) did not, implying that amino acids 671–697 of
DISC1 are important in this interaction (Fig. 4a). Thus,
we produced a construct lacking these amino acids
(DISC1-D671–697) and found that deletion of this region
significantly reduced DISC1-PSD95 binding (Fig. 4b). We
found that while co-expression of full-length DISC1 signi-
ficantly reduced ErbB4-PSD95 binding, co-expression of
DISC1-D671–697 did not affect ErbB4-PSD95 binding (Fig. 4c).
Taken together, our results suggest that DISC1 interferes with
ErbB4-PSD95 binding via its own interaction with PSD95.
Interneuronal DISC1 regulates E–I synapse formation.
NRG1-ErbB4 signalling has been shown to enhance mEPSC
frequency in vitro6,11,12. We therefore hypothesized that
interneuronal knockdown of DISC1 may enhance mEPSC
frequency, possibly as a downstream effect of enhanced
NRG1-ErbB4 signalling. As above, we selectively knocked down
DISC1 in fast-spiking interneurons by cortical injection of AAV
with Cre-dependent shRNA expression into PV-Cre mice.
GFP-positive cells (that is, infected PV interneurons) were
patched in acute slices from these mice in order to record
mEPSCs. We found that mEPSC frequency was increased in cells
with DISC1 knockdown compared with cells expressing control
shRNA (Fig. 5a, b), whereas amplitude of mEPSCs was not
affected (Fig. 5c). DISC1 knockdown did not affect the membrane
properties or intrinsic excitability of PV interneurons
(Supplementary Fig. 10). These results indicate that DISC1
knockdown in interneurons enhances their excitability in
response to pyramidal neurons through increased synapse
formation and/or modification of pre-synaptic elements.
NRG1-ErbB4 signalling in interneurons increases formation of
glutamic acid decarboxylase (GAD65)-positive inhibitory
boutons on the soma and axon initial segment of pyramidal
neurons in the cortex6. This regulation of inhibitory connections
is also reflected electrophysiologically by the effects of NRG1-
ErbB4 signalling on miniature inhibitory postsynaptic current
frequency in pyramidal neurons, in the cortex6,41,42 and
amygdala43. We therefore examined whether loss of DISC1
expression, also enhanced this downstream effect of NRG1-ErbB4
signalling. Synaptosomal fractionation of cortical extracts showed
that the level of synaptic GAD65 was increased in Disc1-LI mice
compared with WT littermates (Fig. 6a). Previous studies showed
no change in GAD65 expression following ErbB4 knockdown7,8.
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Figure 2 | Interneuronal DISC1 knockdown enhances ErbB4 activation and signalling in interneurons in vivo. (a) Western blot for ErbB4 and pErbB4 in
cortical lysates from adult Disc1-LI mice or WT littermates. Disc1-LI mice showed greater pErbB4 signal. (b) Immunostaining for pErbB4 in cortical sections
(layer 3, PFC) from adult Disc1-LI mice or WT littermates. Disc1-LI mice showed greater pErbB4 immunoreactivity in PV-positive cells (arrowheads). Scale
bar, 10 mm. (c) Immunostaining for DISC1 in cortical sections (layer 3, PFC) from PV-Cre mice injected with AAV expressing Cre-dependent shRNA
(Control (Cont) or DISC1) and GFP. Images from two independent and representative fields are shown. DISC1 expression is knocked down exclusively by
DISC1 shRNA, specifically in GFP-positive cells (arrowheads). Scale bar, 10mm. (d) Immunostaining for pErbB4 in PV-Cre mice injected with AAV
expressing Cre-dependent shRNA (Cont or DISC1) and GFP. pErbB4 is increased in GFP-positive cells expressing DISC1 shRNA (arrowheads). Scale bar,
10mm. (e) Immunostaining for pErk in PV-Cre mice injected with AAV-expressing Cre-dependent shRNA (Cont or DISC1) and GFP. pErk is increased in
GFP-positive cells expressing DISC1 shRNA (arrowheads). Blue signal in images represents 4,6-diamidino-2-phenylindole (DAPI) stain. N430 cells from
five mice. Data are represented as mean±s.e.m. *Po0.05, **Po0.01; scale bar, 10mm.
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However, our results probably differ for two reasons. First, the
present study functionally upregulated ErbB4, whereas the
previous studies suppressed ErbB4. Second, the present study
examined ErbB4 in synaptosomal fractions, whereas the previous
studies used total extracts. To more accurately quantify GAD65-
positive perisomatic inhibitory bouton formation on pyramidal
neurons, we co-injected a lentivirus expressing red fluorescent
protein (RFP) under the control of the pyramidal neuron-
specific aCaMKII promoter along with the AAV used for PV
interneuron-specific DISC1 knockdown described above
(Fig. 6b). We then performed immunohistochemistry for
GAD65 in cortical sections. The majority of GAD65-positive
boutons were also GFP-positive, indicating that they come from
infected PV interneurons (Fig. 6c). We observed a significant
increase in both number and size of perisomatic GAD65-positive
boutons following interneuronal DISC1 knockdown in vivo
(Fig. 6d). As these boutons represent inhibitory output from


































































































































































Figure 3 | DISC1 interferes with ErbB4–PSD95 interaction. (a) Co-immunoprecipitation (co-IP) of ErbB4 and PSD95 in lysates from mature primary
cortical neurons infected with shRNA (control (Cont) or DISC1) and treated with NRG1. Top panels, western blot for PSD95, p-tyrosine and ErbB4 in anti-
ErbB4 precipitates; bottom panels, western blot for PSD95 and ErbB4 in input. Cells with DISC1 shRNA showed greater amounts of PSD95 co-precipitating
with ErbB4 and greater levels of NRG1-induced tyrosine phosphorylation of ErbB4. (b) Co-IP of ErbB4 and PSD95 in cortical lysates from adult Disc1-LI mice
or WT littermates. Top panels, western blot for PSD95, p-tyrosine and ErbB4 in anti-ErbB4 precipitates; bottom panels, western blot for PSD95 and ErbB4
in input. Disc1-LI mice showed greater amounts of PSD95 co-precipitating with ErbB4 and greater levels of NRG1-induced tyrosine phosphorylation of
ErbB4. (c) Co-IP of PSD95, DISC1 and ErbB4 in lysates from HEK-293 cells. Cells were transfected with haemagglutinin (HA)-tagged DISC1, ErbB4 and
GFP-tagged PSD95 constructs (full length (FL) or with the following deletions: PDZ domain 1 and 2 (DPDZ1-2), Src homology 3 domain (DSH3) and
guanylate kinase-like domain (DGK)). Top panels, western blot for HA (DISC1) and ErbB4 in anti-GFP (PSD95) precipitates; bottom panels, western blot for
PSD95, ErbB4, DISC1 and GAPDH in input. Amounts of DISC1 and ErbB4 co-precipitating with PSD95-DPDZ1-2 were significantly reduced compared with
PSD95-FL. Data are represented as mean±s.e.m. *Po0.05, **Po0.01, ***Po0.01. N¼ 3 independent experiments.
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novel circuit-level phenotype that is regulated by interneuronal
DISC1.
Discussion
The present work represents the first evidence of direct
involvement of DISC1 in regulating NRG1-ErbB4 signalling in
adult fast-spiking interneurons in a cell-autonomous manner.
Our data suggest that DISC1 negatively regulates ErbB4
activation at excitatory synapses onto PV interneurons. We
observed that DISC1 competed with ErbB4 for binding to PSD95,
which might reduce both ErbB4-PSD95 binding and subsequent
ErbB4 activation. This scenario is the most likely; however, we
note that there is room for alternative interpretations. The
regulation of ErbB4 signalling by DISC1 is likely to be an
important contributor to maintaining excitatory–inhibitory
balance in the healthy adult cortex. We observed that selective
knockdown of interneuronal DISC1 affects two major character-
istics of interneurons affected by NRG1-ErbB4 signalling, that is,
interneuronal mEPSC frequency and inhibitory GAD65 bouton
formation.
There are several technical limitations to this study. First, it is
challenging to study each subpopulation of interneurons in
primary neuron cultures, in part due to their low prevalence. For
this reason, we used GAD67 rather than PV as an interneuronal
marker for immunocytochemistry experiments, in order to
maximize the number of transfected interneurons we could
observe in each culture. We validated our ability to observe
interneuronal ErbB4 activation at the biochemical level in
cultures by immunocytochemistry for pErbB4. We also used an
anti-ErbB4 antibody, rather than anti-PSD95, for ErbB4-PSD95
co-immunoprecipitation in order to exclude any non-interneur-
onal confounding factors (for example, possible changes in
PSD95 expression in pyramidal neurons). It is also difficult to
definitively establish cell-autonomy in vivo. Although the titre of
the virus used did not produce universal infection of PV
interneurons, it is possible that infected interneurons were close
enough to influence each other. However, we believe that this
scenario is unlikely because pyramidal neurons are considered the
major source of NRG1 expression and signalling in the cortex44.
Recent studies suggest that loss of function of DISC1 in
developing interneurons leads to impaired inhibition in the
mature cortex, an opposite effect from our findings of enhanced
interneuronal excitation and inhibitory synapse formation.
However, it is important to note that these studies either use
genetic mutant models of DISC1 (ref. 45), which do not
specifically address the function of interneuronal DISC1, or
















































































































































Figure 4 | DISC1–PSD95 interaction may be important in regulating ErbB4–PSD95 interaction. (a) Co-IP of DISC1 and PSD95 in lysates from HEK-293
cells. Cells were transfected with GFP-tagged PSD95, ErbB4 and haemagglutinin (HA)-tagged truncated DISC1 constructs (N-terminal to amino acid 671
(N-671-HA), 697 (N-697-HA), 726 (N-726-HA) or 748 (N-748-HA)). Top panel, western blot for PSD95 in anti-HA (DISC1) precipitates; bottom panels,
western blot for PSD95 and HA (DISC1) in input. Amounts of PSD95 co-precipitating with DISC1-N-671-HA were significantly reduced compared with
DISC1-N-697-HA, suggesting AA 671–697 as the binding domain for PSD95. (b) Left panel, schematic of full-length DISC1 (FL), truncated DISC1 constructs
and DISC1 deletion construct deficient in binding to PSD95 (DISC1-D671–697); right panel, quantification of co-IP of PSD95 and DISC1-D671–697 deletion
construct. Binding of PSD95 to DISC1-D671–697 was significantly impaired. (c) Co-IP of ErbB4 and PSD95 in lysates from HEK-293 cells. Cells were
transfected with ErbB4, PSD95 and HA-tagged DISC1 constructs (FL or lacking the binding domain for PSD95). Top panel, western blot for PSD95 in anti-
ErbB4 precipitates; bottom panels, western blot for ErbB4, PSD95 and HA (DISC1) in input. Co-transfection of DISC1-FL impaired ErbB4-PSD95 binding,
whereas DISC1-D671–697 did not. Data are represented as mean±s.e.m. **Po0.01. N¼ 3 independent experiments.
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which may confound studies of the role of DISC1 in the adult
brain. In the present study, our goal was to modulate DISC1 in a
subset of cells at a particular time point, independent from the
broader context of DISC1 functioning in vivo. To do this, we use
Cre-dependent viral shRNA expression to specifically target
interneurons in adulthood. This approach allows normal DISC1
expression during development and only knocks down DISC1 in
mature interneurons. We are thus able to study a previously
uncharacterized pool of DISC1 in cortical interneurons of the
mature brain in vivo. Because the time point at which
interneuronal function is disrupted has been shown to affect
cognitive outcomes46, we believe that an approach that can
distinguish adult brain function from early neurodevelopmental
influences is important. The value of studying mechanisms
specific to developmental stages can be appreciated by a recent
study showing that disruption of ErbB4 mainly affected the final
stages of glutamatergic synapse formation onto interneurons8.
Several studies on post-mortem patient brains have shown an
increase in NRG1 and ErbB4 protein and mRNA levels47–49. In
addition, transgenic mice overexpressing NRG1 (analogous
to an ErbB4 gain of function) show schizophrenia-like pheno-
types50–52. Our results are consistent with these lines of evidence,
which indicate that upregulation of NRG1-ErbB4 signalling
underlies mechanisms relevant to schizophrenia. However, we
need to note that loss of function of NRG1-ErbB4 signalling in
rodent models also display schizophrenia-like phenotypes53,54.
Thus, we propose that ErbB4 signalling needs to be in an optimal
range for proper network functioning and deviations above or
below this range result in behavioural outcomes relevant to
schizophrenia. This idea is reminiscent of the fact that both
upregulation and downregulation of dopamine signalling result in
disturbance of cognitive functions55,56.
A recent study of NRG1-ErbB4 signalling in interneurons has
indicated another potential site of cross-talk with DISC1. ErbB4
reportedly interacts with and phosphorylates Kalirin-7 (Kal7),
enhancing Rac1 activation and neurite outgrowth in response to
NRG1 (ref. 57). Given our current finding that DISC1 reduces
NRG1-induced ErbB4 activation, we predict that DISC1 might
also reduce Kal7-Rac1 signalling. This is broadly consistent with
earlier findings from our group, which show that DISC1 impairs
Kal7-Rac1 signalling by tethering Kal7 to PSD95 (ref. 20). Further
studies that specifically target the excitatory postsynaptic density
on mature interneurons will be necessary to fully understand
the interactome responsible for the proper functioning of
these cells.
Human studies have demonstrated interneuron deficits in
schizophrenia by neuropathology and clinico-physiology
(for example, oscillations)58,59. Independently, human studies
also have indicated pyramidal neuron deficits by neuropathology
and genetics60,61. Nonetheless, it is unclear what molecular
mechanisms underlie the overall pathology affecting both
interneuron and pyramidal neurons defects. Our present study
focusing on interneurons, together with recent studies focusing
on pyramidal neurons20, may provide the NRG1-ErbB4-DISC1
pathway as a basis for common driver to bridge pyramidal/
interneuronal pathology in schizophrenia. Future studies that
integrate these findings into the broader context of DISC1
functioning may provide insight into the convergence of genetic
disruptions in mental illness.
Methods
Reagents. Antibodies used in this study were as follows: rabbit anti-phospho-
ErbB4 (Cell Signaling Technologies, 1:1,000, western blotting), rabbit anti-
phospho-ErbB4 (Abcam, 1:2,000, cell staining), rabbit anti-ErbB4 (Santa Cruz
Biotechnology, 1:400), rabbit anti-NRG1 (Santa Cruz Biotechnology, 1:400), rabbit
anti-DISC1 (mExon3 (ref. 62), 1:400), mouse anti-PV (Millipore, 1:500), mouse
anti-GAD67 (Millipore, 1:500), goat anti-GFP (Sigma, 1:500), mouse anti-PSD95
(Millipore, 1:2,000), rabbit anti-phospho-tyrosine (Santa Cruz Biotechnology,
1:400), rabbit anti-phospho-Erk (Cell Signaling Technology, 1:1,000), rabbit
anti-HA (BD Biosciences, 1:1,000), rat anti-RFP (Chromotek, 1:500), rabbit
anti-GAD65 (Millipore, 1:500).
Recombinant protein production and treatment. Recombinant NRG1-b-GST
was produced as previously described32. HEK-293 cells (American Type Culture
Collection) were treated with 10 nM NRG1 for 5 min at 37 C. Primary cortical
neurons were treated with 5 nM NRG1 for 15 min at 37 C. Following treatment,
cells were placed on ice, washed with ice-cold PBS, scraped into lysis buffer and
sonicated.
Recombinant DNA production. The shRNA sequence used to knock down











































Figure 5 | Interneuronal DISC1 knockdown increases interneuronal
excitation. (a) Representative current traces from PV interneurons infected
with shRNA (control (Cont) or DISC1) in acute cortical slices from adult
mice recorded in the whole-cell configuration. Negative peaks represent
mEPSCs. Scale bars, x axis, 500 ms, y axis, 20 pA. (b) Quantification of
mEPSC frequency in recordings from PV interneurons infected with shRNA
(Cont or DISC1). DISC1 knockdown led to an increase in mEPSC frequency.
(c) Quantification of mEPSC amplitude in recordings from PV interneurons
infected with shRNA (Cont or DISC1). DISC1 knockdown did not affect
mEPSC amplitude. Data are represented as mean±s.e.m. *Po0.05. N¼ 5
animals, 27 cells for DISC1 shRNA, 4 animals, 20 cells for Cont shRNA.
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This hairpin fragment was subcloned into a lentiviral vector previously used
by our group32. Oligonucleotides containing the shRNA sequence were
synthesized, annealed and digested using XhoI and EcoRI for insertion into a
published AAV construct containing a floxed-stop codon cassette to allow
Cre-dependent shRNA expression63. Following ligation, One Shot Stbl3
Chemically Competent E. Coli (Invitrogen) were transformed and spread on Luria
Bertani agar plates containing ampicillin to select positive colonies. Plasmid DNA
for all viral constructs was prepared using Endofree Plasmid Maxi kits (Qiagen).





















































































shRNA: Cont DISC1shRNA: Cont DISC1
Figure 6 | Interneuronal DISC1 knockdown increases inhibitory synapse formation on pyramidal neurons. (a) Western blot for GAD65 in synaptosomal
fractions from adult Disc1-LI mice or WT littermates. Disc1-LI mice showed greater levels of synaptosomal GAD65. Synaptophysin was used as a loading
control (Cont). (b) Immunohistochemistry showing lentiviral- and AAV-mediated cell type-specific fluorescent labelling. Pyramidal neurons and
interneurons are individually labelled by RFP and GFP, respectively. (c) Immunohistochemistry for GFP (blue), GAD65 (green) and RFP (red) in PV-Cre
mice injected with AAV. The majority (76%, N¼ 13 cells) of GAD65-positive (GAD65þ ) boutons were also GFP-positive (GFPþ), that is, originating from
infected PV interneurons (arrowheads). Scale bar, 5mm. (d) Top, immunohistochemistry for RFP (red, pyramidal neurons) and GAD65 (green) in PV-Cre
mice with interneuronal shRNA expression (Cont or DISC1). GAD65þ punctae adjacent to RFP-labelled cell bodies, that is, perisomatic GAD65 boutons,
were analysed. Bottom, quantification of GAD65 bouton number and size (area). DISC1 knockdown led to denser and larger perisomatic GAD65 boutons.
Blue signal in images represents 4,6-diamidino-2-phenylindole (DAPI) stain (nucleus). N¼ 14 cells from 4 mice. Data are represented as mean±s.e.m.
*Po0.05, **Po0.01; scale bar, 20mm.
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Virus preparation. Lentivirus was produced by co-transfection of established
lentiviral plasmids20 and packaging vectors (RRE, Rev, VSVG) into HEK-293FT
cells (Invitrogen). Transfection was performed using Lipofectamine 2000 reagent
(Invitrogen) following the manufacturer’s protocol. 48–72 h after transfection,
supernatants were collected and virus was concentrated following our previously
described protocol32. AAV was also generated as previously described63. Briefly,
AAV plasmid and helper constructs were co-transfected into HEK-293 cells using
CaCl2; supernatant and cells were collected 48–72 h later. Virus was precipitated
using (NH4)2SO4, then the precipitate was re-suspended and purified on an
iodixanol gradient by ultracentrifugation. Further concentration of virus was done
using an Amicon Ultra-100 K filter unit (Millipore).
Cell culture and transfection. HEK-293 cells were cultured as previously
described32. Transfection of HEK-293 cells for non-virus experiments was done
using Polyfect reagent (Qiagen) following the manufacturer’s protocol. Dissociated
primary cortical neurons from rats (E19, Sprague–Dawley, Charles River) were also
cultured as previously described20,32. Plasmid DNA for transfection was produced
using the EndoFree Maxiprep kit (Qiagen), and transfection was performed using
Lipofectamine 2000 reagent (Invitrogen) following the manufacturer’s protocol.
Generation of Disc1 LI model. The mouse locus containing Disc1 is closely
syntenic to the human locus. It includes the Tsnax/Trax gene located at 50 to the
Disc1 gene. The 40-kb locus that we deleted covers exons 1, 1b, 2 and 3, as well as
depletes Tsnax/Trax-Disc1 intergenic splicing. We also deleted an miRNA in intron
1, which could alter functions and levels of DISC1, by targeting at least some
DISC1-binding partner genes (such as 14-3-3, CRMP1/2). The targeting scheme
that was applied to delete the Disc1 locus was essentially as described64. Briefly, a
bacterial artificial chromosome-based genomic library generated from C57BL/6J-
129SvEv-hybrid embryonic stem (ES) cell lines (Regeneron) was screened to
identify a Disc1-containing clone that we subsequently modified using a RecA-
mediated recombination strategy to replace the genomic region (B40 kb) with the
neomycin selection cassette. The successfully modified bacterial artificial
chromosome was electroporated into C57BL/6J-129SvEv hybrid ES cell
lines and the targeted clones were identified by Velocigene screening followed by
confirmation via conventional Southern blots. Among three successfully targeted
ES clones injected into C57BL/6J blastocysts, two rendered highly chimeric males,
which transmitted the mutation through the germline when crossed with C57BL/6J
mice. F1 heterozygous offspring from both lines were sufficiently backcrossed with
C57BL/6J to standardize the genetic background, and both mouse lines showed
identical phenotypes. Although body weight was lower, no lethal phenotypes were
observed in the mice.
Stereotaxic injection. Stereotaxic injection into the prefrontal cortex (PFC) of
adult mice was conducted similarly to a previously described protocol20. Adult
mice (4P60, female) were anaesthetized with ketamine and immobilized in a
stereotaxic frame. A scalp incision and small craniotomy were performed under
sterile conditions. Virus was injected using a microinfusion pump and sharp glass
pipette. Coordinates for injection into the PFC are: anterior-posterior
(AP)þ 1.6 mm, medial lateral (ML)±0.5 mm, dorsal-ventral (DV) 1.8 mm.
Following surgery, the incision was closed with sutures and the mouse was allowed
to awaken completely before being returned to its cage. All experiments involving
animals were performed in compliance with the Institutional Animal Care and Use
Committee.
Co-immunoprecipitation and western blotting. Co-immunoprecipitation was
performed as previously described32,65. Protein lysates were prepared by cell
scraping or tissue homogenization in lysis buffer (20 mM Tris (pH 7.4), 150 mM
NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium
pyrophosphate, 1 mM b-glycerolphosphate, 1 mM Na3VO4 and 1 mM Pefabloc
(Roche Applied Science)). Lysates were pre-cleared with 25 ml Protein A/G Agarose
beads (Chemicon) and 1 mg IgG, before incubation with precipitating antibody
overnight at 4 C. Samples were then incubated for 1 h with 50 ml Protein A/G
Agarose beads, spun down and washed three or four times with lysis buffer or PBS,
then boiled in sample buffer for 2–10 min. For western blotting, 20 ml of sample
containing up to 50mg total protein was loaded in a Novex 8% Tris-Glycine gel
(Life Technologies) and run at room temperature, followed by transfer to a PVDF
membrane (Thermo Scientific). Membranes were blocked for 1 h in 5% milk in
PBS, incubated with primary antibody overnight, then with secondary antibody
(goat anti-mouse or anti-rabbit HRP, Thermo Scientific) for 2 h at room
temperature before exposure and quantification (see Supplementary Methods for
details). For phospho-specific antibodies, tris-buffered saline (TBS) and 5% bovine
serum albumin were used instead of PBS and 5% milk, respectively.
Immunohistochemistry and immunocytochemistry. Mouse brains were perfused
with 4% paraformaldehyde, cryoprotected using 20 and 30% sucrose in PBS,
mounted in optimal cutting temperature reagent and sectioned at 20 mm thickness
using a cryostat. Frozen sections or cultured cells on coverslips were fixed with
3.7% formaldehyde for 10 min at room temperature. Sections or coverslips were
blocked with TBS containing 1% BSA, 5% normal goat serum and 0.2% Triton
X-100 followed by incubation in primary antibody overnight at 4 C, washing with
TBS, incubation in secondary antibody for 2 h at room temperature, TBS washing
and labelling with 4,6-diamidino-2-phenylindole (Amersham, 1:10,000) and
mounting using ProLong Gold antifade reagent.
Electrophysiology. Electrophysiological recordings from acute cortical slices were
performed as previously described66. Briefly, fluorescent illumination was used to
target GFP-positive cells in layer 3 of PFC and whole-cell recordings were obtained
with Multiclamp 700B amplifiers (Molecular Devices). Cortical slices of 300 mm
thick were perfused at room temperature (27 C) in artificial cerebrospinal fluid
containing 119 mM NaCl, 2.5 mM KCl, 2 mM CaCl2, 2 mM MgCl2, 26 mM
NaHCO3, 1 mM NaH2PO4 and 11 mM glucose and were gassed with 5% CO2/95%
O2 (pH 7.4). Patch recording pipettes (3–5 MO) were filled with internal solution
containing 115 mM cesium methanesulfonate, 20 mM CsCl, 10 mM HEPES,
2.5 mM MgCl2, 4 mM Na2ATP, 0.4 mM Na3GTP, 10 mM Na-phosphocreatine and
0.6 mM EGTA (pH 7.25). mEPSCs were recorded in artificial cerebrospinal fluid
including 1 mM tetrodotoxin and 100 mM picrotoxin (Sigma-Aldrich) and analysed
using Mini Analysis Program (Synaptosoft, Inc.). Stable recordings were obtained
for at least 10 min and 350 events per cell were used for analysis. At least 20 cells
from four or more animals were analysed per condition.
Subcellular fractionation. Fractionation of mouse brains was performed as pre-
viously described67. Briefly, dissected cortices were dounce homogenized in TEVP
buffer (10 mM Tris-HCl, pH 7.4, 5 mM NaF, 1 mM Na3VO4 and complete protease
inhibitor (Roche)) with 320 mM sucrose and centrifuged at 1,000g for 10 min to
obtain pellet P1 and supernatant S1. S1 was centrifuged at 10,000g for 10 min to
obtain P2 and S2. P2 was lysed hypo-osmotically and centrifuged at 25,000g for 1 h
to obtain pellet LP1. S2 was centrifuged at 165,000g for 1 h to obtain P3 and S3.
LP1 and P3 were re-suspended in TEVP and sonicated once.
GAD65 bouton measurement. GAD65 bouton formation was measured similarly
to published protocols68. Briefly, perfused cortical sections were stained with GFP,
RFP and GAD65, and confocal z-stacks containing labelled cells were captured at
 63 magnification. Stacks were imported into ImageJ and images of pyramidal
neurons in which the optical plane contains the largest soma profile were
quantified. Pyramidal neurons (visually defined by RFP) were traced and an area
within 2 mm of the cell surface is analysed for GAD65 immunoreactive punctae,
with area between 0.15 and 2.5 mm2 (ref. 69). GAD65 signal, not GFP, was used to
define boutons. Quantification was done blind to the shRNA condition.
Statistical analysis. The significance of inter-group differences was calculated
using GraphPad Prism 5 software. For analyses of two groups, P-values are
determined by t-test with equal variances or t-test with unequal variances after
variances of two groups were tested by F-test. For analyses of three or more groups,
P-values were determined by one-way analysis of variance followed by Bonferroni
post hoc corrections.
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